Products

Co-Ablation
Hygea Medical Technology Co., Ltd.
Oncology AI
The Co-Ablation System by Hygea Medical Technology Co., Ltd. is an advanced medical device integrating cryoablation and hyperthermia for precise, minimally invasive tumor destruction in interventional oncology.

See all 1 product →

About Hygea Medical Technology Co.

Hygea Medical Technology Co., Ltd., established in 2010 and headquartered in Beijing, China, is a National High-tech Enterprise specializing in advanced medical devices for interventional oncology. The company focuses on both percutaneous and transvascular intervention techniques, aiming to provide minimally invasive treatment platforms for various solid tumors. Its flagship product, the Co-Ablation System, is a pioneering device globally, integrating both cryoablation and hyperthermia ablation within a single system. This innovative approach allows for precise tumor destruction while maintaining a strong safety profile, as evidenced by recent clinical data.

Clinical evidence published in the European Journal of Radiology in January 2026 demonstrated the Hygea Co-Ablation System’s safety and feasibility for treating malignant lung tumors. The study reported acceptable adverse event rates, significantly lower rates of pleural effusion and hemoptysis, and favorable local tumor control, particularly for lesions ≤3 cm, alongside prolonged progression-free survival in small lesions. The company’s product portfolio also includes an EXCEED™ microwave ablation system, which received U.S. FDA approval in early 2024, further expanding its capabilities in thermal ablation for soft tissues and various solid tumors. Hygea Medical is committed to continuous innovation, holding over 150 patents and having treated more than 10,000 patients across over 100 hospitals.

Hygea Medical’s technology is applicable across a broad spectrum of oncological indications, including lung, liver, pancreas, and bone cancers, as well as prostate, female genitalia, skin, anus, and rectum tumors. The systems are designed for use in open, minimally invasive, or endoscopic surgical procedures. Beyond tumor ablation, their technology also extends to pain management through cryoanalgesia. The company’s dedication to advancing minimally invasive cancer treatment is underscored by its ongoing research and development, including the application of artificial intelligence in surgical treatment for tumors.

What Physicians Need to Know

Specialization
Hygea Medical Technology Co. specializes in advanced medical devices for interventional oncology, particularly in minimally invasive percutaneous and transvascular interventions for solid tumor treatment. [7, 8, 11]
Core Technology
Their flagship product is the Co-Ablation System, which uniquely integrates both cryoablation (ultra-low temperatures down to -196u00b0C using liquid nitrogen) and high-intensity thermal ablation (hyperthermia up to 80u00b0C using ethanol) within a single system. [1, 4, 6, 8, 10, 11, 13]
AI Integration (AI Epic Series)
The 'AI Epicu2122' series of Co-Ablation Systems incorporates technological innovation, including a wireless full-featured tablet with an intuitive UI design and a surgery planning feature, suggesting AI-enhanced capabilities for procedural guidance and optimization. [4, 8]
Clinical Applications
The system is indicated for destroying solid tumors across a broad range of areas, including lung, liver, bone, pancreas, breast, prostate, kidney, and skin lesions, as well as in general surgery, urology, gynecology, oncology, neurology, dermatology, ENT, proctology, pulmonary, and thoracic surgery. [2, 4, 13]
Clinical Validation
Clinical evidence, including large retrospective studies and randomized controlled trials, demonstrates the safety and feasibility of the Hygea Co-Ablation System for malignant lung tumors, showing non-inferiority to traditional cryoablation methods. [1, 3]
Intellectual Property & Recognition
The company holds over 150 Chinese and international patents and its AI Epic series Co-Ablation System received the iF DESIGN AWARD 2020. [8, 9, 11]
Physician Tip

For physicians, Hygea Medical Technology Co.'s Co-Ablation System offers a versatile, minimally invasive option for solid tumor treatment. The integration of both cryoablation and hyperthermia provides enhanced precision and control, potentially leading to improved patient outcomes by minimizing complications like probe tract bleeding and tumor seeding. [1, 4] The 'AI Epic' series, with its intuitive interface and surgery planning features, can aid in complex case management and procedural efficiency. [8] Consider its application across various tumor types and surgical specialties, leveraging the strong clinical evidence supporting its safety and efficacy. [1, 3, 13]

The Co-Ablation System operates under CT image guidance, indicating a direct integration with existing diagnostic imaging infrastructure in clinical settings. [3, 6, 10] While the 'AI Epic' series features a wireless tablet and intuitive UI for surgery planning, specific details regarding integration with Electronic Medical Records (EMRs) or broader hospital information systems are not explicitly provided in the available information. Integration would primarily involve imaging data for planning and procedural execution, and potentially data export for patient records.

Products by Hygea Medical Technology Co.

1 product in the directory

Co-Ablation
Hygea Medical Technology Co., Ltd.
Oncology AI
The Co-Ablation System by Hygea Medical Technology Co., Ltd. is an advanced medical device integrating cryoablation and hyperthermia for precise, minimally invasive tumor destruction in interventional oncology.

What the Web Says

Hygea Medical Technology Co. appears to be a company focused on medical devices, particularly ablation systems for tumors. While specific product reviews from major platforms like G2 or Capterra are not readily available, there is clinical evidence supporting their ablation system for lung tumors. Employer reviews are scarce, suggesting a smaller or less publicly reviewed company.

Overall: Mixed

Strengths

  • Clinical evidence supports the efficacy of their ablation system for lung tumors.
  • Focus on innovative medical technology.
  • Potential for advancements in cancer treatment.
  • Specialized in a critical area of healthcare.

Limitations

  • Lack of readily available product reviews on major platforms (G2, Capterra).
  • Limited employer reviews on Glassdoor, making it difficult to assess company culture.
  • No significant discussions found on Reddit regarding products or employment.
  • Information primarily from their own website, limiting independent third-party opinions.

Based on reviews from: Hygea Medical Technology Co. website (news section), Limited search results from G2, Glassdoor, Capterra, Reddit, and general healthcare IT reviews

Last updated: 2026-07-20

Videos

News, demos, and interviews about Hygea Medical Technology Co..

Loading videos...

Videos load interactively. If none appear, search YouTube for Hygea Medical Technology Co. →

View all on YouTube

Press & Coverage

Hygea Medical Technology Co., Ltd.
Hygea Co-Ablation System for Lung Tumors: Clinical Evidence from a Large Retrospective Study
New clinical data published in the European Journal of Radiology demonstrates that the Hygea Co-Ablation System is a safe and feasible option for treating malignant lung tumors, showing acceptable adverse event rates and favorable local tumor control.
2026-01
Hygea Medical Technology Co., Ltd.
Hygea Medical to Exhibit at ECIO 2026 in Basel
Hygea Medical announced its participation in the European Conference on Interventional Oncology (ECIO) 2026, taking place from April 26 to 30 in Basel, Switzerland.
2026-04
Hygea Medical Technology Co., Ltd.
ISMIO 2025: Hygea Symposium Unites Nations on Cutting-Edge Tumor Ablation Techniques
The ISMIO 2025 Annual Conference featured a dedicated symposium on tumor ablation and cryo-thermal techniques, where Hygea Medical's Co-ablation system was highlighted for its clinical advances.
2025-06
Hygea Medical Technology Co., Ltd.
Hygea and SHAHCO Sign Landmark MoU for Cancer Care in Pakistan, Witnessed by the Prime Minister of Pakistan
Hygea Medical Technology Co., Ltd. and SHAHCO signed a Memorandum of Understanding for cancer care in Pakistan, with the Prime Minister of Pakistan witnessing the significant ceremony.
2025-09
Hygea Medical Technology Co., Ltd.
Minimally Invasive Ablation Leading the Future u2014 Hygea Showcases Two Flagship Products at CIRSE 2025
Hygea Medical showcased its AI Epicu2122 Co-ablation System and Exceedu2122 Microwave Ablation System at the 2025 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Congress.
2025-09
Hygea Medical Technology Co., Ltd.
The first randomized phase II trial evaluating ablation plus immunotherapy in advanced NSCLC with oligo-residual disease
The BOOSTER study provides the first prospective evidence that adding local ablation to ongoing antiu2013PD-1/L1 therapy can improve disease control in advanced NSCLC patients with oligo-residual disease.
2025-11
EqualOcean
Hygea Medical Nets Over CNY 100 Mn in Series D
Hygea Medical completed a CNY 100 million Series D funding round, led by In Capital, to strengthen business expansion, R&D pipelines, and accelerate international strategy.
2023-02
South Africa Today
Beijign Based Medical Technology Company HYGEA Med Raised Nearly uffe5200 Million in a Series B Round Funding
HYGEA Med raised nearly uffe5200 million in a Series B funding round, led by Jianxing Medical Fund, to improve market coverage, accelerate product R&D, and launch international strategy.
2019-12

Frequently Asked Questions

Hygea Medical Technology Co. primarily offers the AI Epicu2122 Co-Ablation System, which integrates cryoablation and hyperthermia for precise tumor destruction in minimally invasive procedures. This system includes features like intuitive UI design and surgery planning capabilities, alongside an AI Surgery Planning Software. The company is committed to further promoting AI applications in minimally invasive surgical tumor treatment across its product lines.
Hygea Medical Technology Co.'s Co-Ablation System received CE Marking Certificate in 2020 for European markets. More recently, their EXCEEDu2122 microwave treatment system and EXACTu2122 series of microwave ablation probes obtained U.S. FDA permission in January 2024, followed by FDA approval for the Co-Ablation System with Sterile Co-Ablation Probe in January 2025. These approvals signify adherence to international safety and performance standards.
While specific details on AI data security protocols are not explicitly detailed, Hygea Medical Technology Co. operates under stringent regulatory frameworks. Their FDA approvals for devices like the Co-Ablation System mandate compliance with Quality System (QS) regulation (21 CFR Part 820), which includes requirements for design controls and good manufacturing practices, implying adherence to data handling standards for medical devices.
Hygea Medical Technology Co. highlights that its AI Epicu2122 Co-Ablation System delivers technological innovation with exceptional clinical outcomes, enabling enhanced precision and powerful ablation performance. The company has published clinical cases and studies related to the Co-Ablation System's application in various cancers, including lung, bone, liver, and pancreas. They also showcase publications and videos demonstrating the system's efficacy and safety.
Hygea Medical Technology Co.'s AI Epicu2122 Co-Ablation System features an intuitive UI design and surgery planning capabilities, suggesting a focus on seamless integration into clinical practice. They also offer an AI preoperative planning system, which indicates an effort to streamline the planning phase of interventional oncology procedures. While specific EMR integration details are not provided, the design emphasizes user-friendliness and workflow enhancement.
Hygea Medical Technology Co. provides contact information for inquiries, indicating direct customer support channels. As a medical device manufacturer with international regulatory approvals, it is expected they offer comprehensive technical support and training programs to ensure safe and effective use of their advanced AI-powered ablation systems.
Founded in 2010, Hygea Medical Technology Co. is a National High-tech Enterprise with over 150 patents and a track record of serving 200+ hospitals and treating 20,000+ patients. The company secured 500 million RMB in Series C financing in 2021, with investments from major firms including AI leader SenseTime, demonstrating strong financial backing and a commitment to continuous innovation in medical devices and AI applications.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.